Lv4
630 积分 2024-03-08 加入
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
3小时前
待确认
Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis
2天前
已完结
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
2天前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
2天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
2天前
已完结
Enzyme-converted O kidneys allow ABO-incompatible transplantation without hyperacute rejection in a human decedent model
2天前
已完结
Induction of Immune Tolerance in Living Related HLA-Matched Kidney Transplantation: A Phase 3 Randomized Clinical Trial
2天前
已完结
Normothermic Ex Vivo Perfusion Before Transplantation of the Kidney (NEXT-Kidney): A Single-center, Nonrandomized Feasibility Study
2天前
求助中
Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis
2天前
已完结
Multifaceted innovations needed to advance transplant nephrology
2天前
已完结
皖公网安备34019202002308
